Vol. 41 No. 4 (2024)

Click for printable Cover

Published: 10-12-2024

  • Insights into the paradoxical effect of smoking on vasculitis: a comprehensive review

    Alireza Khabbazi, Mehran Rahimi, Aida Malek Mahdavi, Rojin Farzaneh, Sara Daneshvar, Amirreza Naseri, Saman Beig Zali, Ehsan Nasiri
    e2024053
    DOI: https://doi.org/10.36141/svdld.v41i4.15557

  • Pulmonary rehabilitation in connective tissue disease-associated interstitial lung disease: A systematic review

    Irem Seleoglu, Aynur Demirel
    e2024061
    DOI: https://doi.org/10.36141/svdld.v41i4.15633

  • Comparing the utility of lung function parameters and fractional exhaled nitric oxide in predicting lung cancer

    Hongli Cao, Xianyang Chen, Yige Song, Teng Xue, Zhongwen Xue, Guosheng Zhang, Kun Wang, Zijin Liu
    e2024065
    DOI: https://doi.org/10.36141/svdld.v41i4.14694

  • Diagnostic yield of a novel tracer 68Ga-citrate in sarcoidosis patients 68Ga-citrate PET/CT in sarcoidosis

    Cuneyt Tetikkurt, Bahar Kubat, Haluk Burcak Sayman, Halil Yanardag, Muammer Bilir
    e2024064
    DOI: https://doi.org/10.36141/svdld.v41i4.15207

  • Prolonged corticosteroid therapy and lung abnormalities in patients after severe COVID-19 pneumonia

    Anja Ljilja Posavec, Daria Cvetković Kučić, Nikola Zagorec, Linda Malnar, Kristina Lalić, Marina Zelenika, Ivona Kovačevič, Dinka Kušter, Andreja Mutvar, Nevenka Piskač Živković
    e2024052
    DOI: https://doi.org/10.36141/svdld.v41i4.14331

  • Interstitial lung disease: retrospective study of the prognostic impact of acute exacerbations

    Joana Pacheco, Ana Isabel Santos, Maria Joana Catarata, Sara Freitas
    e2024051
    DOI: https://doi.org/10.36141/svdld.v41i4.15198

  • Comparison of methotrexate and methylprednisolone as addition to antifibrotic therapy in progressive pulmonary fibrosis due to COVID-19

    Buğra Kerget, Burcu Nur Gülbahar, İsmail Çınar, Fatih Alper, Leyla Sağlam
    e2024054
    DOI: https://doi.org/10.36141/svdld.v41i4.15614

  • Prevalence of SARS-COV-2 infection and outcomes in Greek sarcoidosis patients

    Ourania S. Kotsiou, Paraskevi Kirgou, Argyrios Tzouvelekis, Lykourgos Kolilekas, Effrosyni D. Manali , Spyros A. Papiris , Despina Papakosta, Katerina Antoniou, Ilias Papanikolaou, Paschalis Steiropoulos, Ioannis Tomos, Theodoros Karampitsakos, Anastasia Levounets, Evagelia Fouka, Georgios Spyropoulos, Semeli Mastrodimou, Ourania Papaioannou, Maria Kallieri, Nikoleta Kosmidou, Nikoleta Bizymi, Nikolaos G. Zikos , Ilias E. Dimeas , Foteini Malli, Zoe Daniil
    e2024055
    DOI: https://doi.org/10.36141/svdld.v41i4.15661

  • Lung cancer in patients with pulmonary fibrosis: characteristics features and prognosis

    Sibel Kara, Nesrin Mogulkoc, Gamze Kirkil, Erdogan Cetinkaya, Omer Ozbudak, Talat Kilic, Fatma Demirci Ucsular, Baris Demirkol, Dildar Duman, Gulistan Karadeniz, Nurhan Koksal, Yasemin Soyler, Hulya Gunbatar, Ozlem Oruc, Utku Tapan, Kubra Elif Akbas, Omer Selim Unat
    e2024050
    DOI: https://doi.org/10.36141/svdld.v41i4.15675

  • Sarcoidosis in north African people: about 35 cases

    Rahma Gargouri, Wafa Fenina, Mohamed Al Juaidi, Walid Feki, Hela Fendri, Sameh Msaed, Nedia Moussa, Zeineb Mnif, Samy Kammoun
    e2024060
    DOI: https://doi.org/10.36141/svdld.v41i4.15747

  • Quality of life, fatigue and markers in sarcoidosis: A section from Turkey

    Mustafa Ilteris Bardakci, Gulhan Ayhan Albayrak
    e2024049
    DOI: https://doi.org/10.36141/svdld.v41i4.15760

  • Autoantibodies in sarcoidosis: Innocent bystander or promising biomarker for organ involvement?

    Riccardo Pozzan, Francesco Salton, Paola Confalonieri, Liliana Trotta, Mariangela Barbieri, Nicolò Reccardini, Chiara Torregiani, Gianluca Screm, Michael Hughes, Elisa Baratella, Marco Confalonieri, Lucrezia Mondini, Barbara Ruaro
    e2024056
    DOI: https://doi.org/10.36141/svdld.v41i4.16043

  • Eruptive cutaneous sarcoidosis – A rare phenomenon

    Almog Badash, Lacey Zimmerman, Yonatan Hirsch, Nadera Sweiss, Roger Haber
    e2024058
    DOI: https://doi.org/10.36141/svdld.v41i4.16315

  • Digital sarcoidosis with nail dystrophy

    Michelle Sikora, Kristen I. Lo Sicco, Sara Stream, Avrom S. Caplan
    e2024059
    DOI: https://doi.org/10.36141/svdld.v41i4.16349

  • Mandibular and periodontal involvement in sarcoidosis

    Lauran Zeineddine, Divya Patel, Diana Gomez-Manjarres, Donald M. Cohen, Johnny F. Jaber
    e2024062
    DOI: https://doi.org/10.36141/svdld.v41i4.15860

  • Sarcoidosis after Alemtuzumab therapy: Is Alemtuzumab posing a threat to its patients?

    Misbah Nizamani
    e2024036
    DOI: https://doi.org/10.36141/svdld.v41i4.15873

  • Comparative analysis of COVID-19-related mortality risk in chronic lower respiratory disease and interstitial lung disease

    George W. Hafzalla, Hyein Ji, Niranjan Jeganathan
    e2024057
    DOI: https://doi.org/10.36141/svdld.v41i4.16139

  • Online survey on existing sarcoidosis registries and biobanks: an ERN lung initiative.

    Miriana D'alessandro, Tommaso Pianigiani, Laura Bergantini, Paolo Cameli, Elena Bargagli, Elisabetta Balestro, Eda Börner, Francesco Bonella
    e2024063
    DOI: https://doi.org/10.36141/svdld.v41i4.16074